DEF 14AFBLGCIK 0001958777

FibroBiologics, Inc.

Name: SEC EDGAR filing 0001193125-25-323667
Creator: FibroBiologics, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed December 18, 2025.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Read the filing on SEC.gov All documents in this filing

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001193125-25-323667
Filer: FibroBiologics, Inc.
Ticker: FBLG
CIK: 0001958777
Form type: DEF 14A
Form description: Proxy statement
Filed at: December 18, 2025
Period of report: December 18, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 856.2 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from FibroBiologics, Inc.

See all 41 filings from FibroBiologics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1958777/000119312525323667/0001193125-25-323667-index.htm ↗

Filer's full EDGAR submission history

EDGAR · FibroBiologics, Inc. (0001958777) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.